These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 25202818

  • 1. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease.
    Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby N, Bankir L, Bichet DG.
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4656-63. PubMed ID: 25202818
    [Abstract] [Full Text] [Related]

  • 2. Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study.
    Roussel R, Matallah N, Bouby N, El Boustany R, Potier L, Fumeron F, Mohammedi K, Balkau B, Marre M, Bankir L, Velho G.
    Am J Nephrol; 2015 Dec; 42(2):107-14. PubMed ID: 26346607
    [Abstract] [Full Text] [Related]

  • 3. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
    Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT.
    Nephrol Dial Transplant; 2012 Nov; 27(11):4131-7. PubMed ID: 22523115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?
    Casteleijn NF, Zittema D, Bakker SJ, Boertien WE, Gaillard CA, Meijer E, Spithoven EM, Struck J, Gansevoort RT.
    Am J Nephrol; 2015 Nov; 41(3):248-56. PubMed ID: 25926129
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gender and renal function influence plasma levels of copeptin in healthy individuals.
    Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL.
    Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
    [Abstract] [Full Text] [Related]

  • 10. Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population.
    Tasevska I, Enhörning S, Christensson A, Persson M, Nilsson PM, Melander O.
    Am J Nephrol; 2016 Feb; 44(1):22-8. PubMed ID: 27347674
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.
    Krane V, Genser B, Kleber ME, Drechsler C, März W, Delgado G, Allolio B, Wanner C, Fenske W, 4D and LURIC study investigators.
    Clin Chem; 2017 May; 63(5):997-1007. PubMed ID: 28280053
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus.
    Villela-Torres ML, Higareda-Mendoza AE, Gómez-García A, Alvarez-Paredes AR, García-López E, Stenvikel P, Gu HF, Rashid-Qureshi A, Lindholm B, Alvarez-Aguilar C.
    Arch Med Res; 2018 Jan; 49(1):36-43. PubMed ID: 29665969
    [Abstract] [Full Text] [Related]

  • 15. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
    Blanchard A, Steichen O, De Mota N, Curis E, Gauci C, Frank M, Wuerzner G, Kamenicky P, Passeron A, Azizi M, Llorens-Cortes C.
    J Clin Endocrinol Metab; 2013 May; 98(5):2084-9. PubMed ID: 23515451
    [Abstract] [Full Text] [Related]

  • 16. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States.
    Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J.
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1046-52. PubMed ID: 21289257
    [Abstract] [Full Text] [Related]

  • 17. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E, Machowska A, Stenvinkel P, Lindholm B.
    Curr Protein Pept Sci; 2017 Apr; 18(12):1232-1243. PubMed ID: 28714397
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.